Inventor
FRITZEMEIER KARL-HEINRICH
DE31 patents
⚠️ This page may combine multiple inventors who share the name “FRITZEMEIER KARL-HEINRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
29 patentsUS6958327B1Oct 25, 2005
18 Norsteroids as selectively active estrogens
SCHERING AG88 citations97
US7414043B2Aug 19, 2008
9-α-substituted estratrienes as selectively active estrogens
SCHERING AG56 citations93
US6548534B2Apr 15, 2003
Nonsteroidal gestagens
SCHERING AG20 citations92
US6344454B1Feb 5, 2002
Nonsteroidal gestagens
SCHERING AG29 citations92
US6245804B1Jun 12, 2001
Nonsteroidal gestagens
SCHERING AG34 citations92
US7378404B2May 27, 2008
8β-hydrocarbyl-substituted estratrienes for use as selective estrogens
SCHERING AG52 citations91
US6844336B2Jan 18, 2005
4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity
SCHERING AG14 citations83
US5232915AAug 3, 1993
9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroids
SCHERING AG14 citations74
US6790842B1Sep 14, 2004
11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
SCHERING AG7 citations73
US6166075ADec 26, 2000
Antiestrogens, process for their production and their pharmaceutical use
SCHERING AG10 citations73
US5827842AOct 27, 1998
14α, 17α-C2 -bridged norprogesterone derivatives
SCHERING AG6 citations73
US6780855B2Aug 24, 2004
11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
SCHERING AG8 citations72
US5656622AAug 12, 1997
15,15-dialkyl-substituted derivatives of estradiol
SCHERING AG7 citations68
US7074829B2Jul 11, 2006
Antiestrogens, process for their production and their pharmaceutical use
SCHERING AG3 citations62
US6670347B2Dec 30, 2003
19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring
SCHERING AG2 citations62
US5523298AJun 4, 1996
Progestationally active 19,11-bridged 4-estrenes
SCHERING AG4 citations62
US7109360B1Sep 19, 2006
16-hydroxyestratrienes as selectively active estrogens
SCHERING AG6 citations61
US5236912AAug 17, 1993
Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids
SCHERING AG5 citations60
US6596713B1Jul 22, 2003
Steroid esters and amides, process for their production and their pharmaceutical use
SCHERING AG2 citations57
US7119082B2Oct 10, 2006
11β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring
SCHERING AG0 citations52
US6794409B2Sep 21, 2004
Use of ERβ-selective ligands for regulating fertility and compounds useful therefor
SCHERING AG1 citations51
US6559181B1May 6, 2003
Antiestrogens, process for their protection and their pharmaceutical use
SCHERING AG0 citations51
US6147065ANov 14, 2000
14-α, 17-α-C2 bridged norprogesterone derivatives
SCHERING AG0 citations51
US5703066ADec 30, 1997
Progestationally active 19,11-bridged 4-estrenes
SCHERING AG1 citations51
US5418227AMay 23, 1995
14,16β-ethano-15β, 16(1)-cyclo-14β-estra-1,3,5(10)-trienes
SCHERING AG0 citations51
US5491137AFeb 13, 1996
14α17α-(Propano-and 172 propeno) -estratrienes
SCHERING AG0 citations50
US5389624AFeb 14, 1995
Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids
SCHERING AG0 citations50
US6229029B1May 8, 2001
11β-aryl substituted 14,17-ethanoestratriens, method for the production of these compounds and their use in the production of medicaments
SCHERING AG1 citations47
US6790843B1Sep 14, 2004
C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof
SCHERING AG0 citations45